PILA (PILA) News
Track canonical SquawkNews coverage tagged to PILA, PILA. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Pila Pharma invites investors to H1 report Q&A on 27 August
Pila Pharma has invited investors to review its H1 report with Q&A on 27 August at 11:00 CET.
EQUITY | Aug 27, 2026, 07:10 AM UTC
L
Pila Pharma reports H1 operating loss of SEK 3.85 mln
Pila Pharma posted an H1 operating loss of SEK 3.85 mln.
EQUITY | Aug 27, 2026, 07:02 AM UTC
L
PILA regulatory approval and improved solvency cited in half-year results
TradingView News reports PILA regulatory approval for a key obesity trial and improved solvency highlighted in its half-year results.
EQUITY | Aug 27, 2026, 06:32 AM UTC
L
Pila Pharma publishes interim report for H1 2026
Pila Pharma has published its interim report covering 1 January to 30 June 2026.
EQUITY | Aug 27, 2026, 06:30 AM UTC